The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global live cell imaging market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
Live cell imaging is a microscopy technique that allows in vivo imaging of cell structures. It helps scientists obtain valuable information on biological processes, including molecular localization and movement with time resolution. It also assists in studying dynamic complex assembly and interaction between molecules, viral particle behavior, and cellular responses to environmental cues. With recent advances in technologies, such as algorithms and data analysis, live cell imaging can monitor molecules within animals.
The significant growth in the incidence of chronic and lifestyle diseases, in confluence with expanding healthcare provision, is escalating the need for new generation drugs and formulations. This represents one of the major factors influencing the market positively. Moreover, as live cell imaging is representative of dynamic cells, it can be used to monitor endocytosis, exocytosis, cellular integrity, protein trafficking, signal transduction, and enzyme activity. As a result, it is gaining adoption around the world over fixed cell imaging that usually requires a high illumination intensity and long exposure time. Apart from this, improvements in camera technology, pixel density, and sensitivity are leading to advances in quantitative phase contrast. These advances in quantitative phase contrast technology are enabling capturing of images at different focal planes from one exposure, thereby allowing for better three-dimensional (3D) imaging. As these images can also be automatically processed to extract information from dynamic cells, researchers across the globe are using live cell imaging to get biologically relevant data. Furthermore, the rising government funding and investments, along with private companies, in medical research and development (R&D) projects are anticipated to offer a positive impact on the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global live cell imaging market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and technology.
Breakup by Product:
Breakup by Application:
Breakup by Technology:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc, Olympus Corporation, PerkinElmer Inc and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, Technology, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Becton Dickinson and Company, Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc, Olympus Corporation, PerkinElmer Inc and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at